Prostat Kanseri Tedavisinde Yüksek Doz Hızında Brakiterapi Uygulaması
Yıl: 2016 Cilt: 32 Sayı: 2 Sayfa Aralığı: 92 - 98 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022
Prostat Kanseri Tedavisinde Yüksek Doz Hızında Brakiterapi Uygulaması
Öz: Prostat kanseri kansere bağlı ölümler arasında önemli bir yer tutmaktadır. Prostat kanseri tedavisinde brakiterapi uygulaması son 20 yıl içerisinde değer kazanmıştır. Prostat kanseri tedavisinde brakiterapi en az prostatektomi kadar etkin tedavi sonuçlarını daha az yan etki ile sağlar. Yüksek doz hızında (High dose rate: HDR) brakiterapi uygulaması genellikle eksternal radyoterapiye ek olarak boost amaçlı kullanılmakla birlikte, tek başına düşük doz hızında (Low dose rate: LDR) brakiterapiye alternatif olarak da kullanılabilir. HDR monoterapisi kısıtlı klinik deneyim nedeniyle kontrollü çalışmalar dışında kullanılmamaktadır. LDR brakiterapiden farklı olarak kapsül ve seminal vezikül invazyonu olan hastalarda HDR brakiterapi uygulanabilmektedir. Bu uygulama minimal invaziv bir prosedür sonrası hızlı bir iyileşme ile sonuçlanan ayaktan tedavi özelliğine sahiptir. Bununla birlikte, uzun dönem sekel ya da ciddi yan etki gelişme riski cerrahi yöntemlere göre daha azdır. Erektil disfonksiyon açısından da daha iyi bir korunma sağlar.
Anahtar Kelime: Konular:
High Dose Rate Brachytherapy Application in Prostate Cancer Treatment
Öz: Prostate cancer is an important cause of cancer releateddeaths. Brachytherapy application in patients with prostatecancer has gained value increasingly in the last 20 years.Effective treatment outcomes with much lower side effects atleast as prostatectomy can be achieved with brachytherapy.Although high dose rate (HDR) brachytherapy applicationis used in addition to external radiotherapy as boost dose, itcan be used as monotherapy for an alternative to low doserate (LDR) brachyterapy.Nevertheless, due to limited clinicalexperience, HDR monotherapy is not recommendedexcept in controlled clinical trials. Differently from LDR,HDR brachytherapy can be used in patients with invasionof prostatic capsul and/or seminal vesicle.This applicationis a minimal invazive procedure and ambulatory treatmentresulting in a quick recovery. Development of long term sequelaeor serious side effects are lower than those of surgicalprocedures. At the same time it also provides a betterprotection in terms of erectile dysfunction.
Anahtar Kelime: Konular:
Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık
- 1. Futterer JJ. MR imaging in local staging of prostate cancer. Eur J Radiol 2007;63(3):328-34. http://dx.doi.org/10.1016/j.ejrad.2007.06.029
- 2. Pasteau G, Degrais C. De l'emploid uradium dans le traitment des cancers de la prostate. J Urol Med Chir 1913;4:341-66.
- 3. Aronowitz JN. Dawn of prostate brachytherapy: 1915- 1930. Int J Radiat Oncol Biol Phys 2002;54(3):712-8. http://dx.doi.org/10.1016/S0360-3016(02)02987-5
- 4. Zelefsky MJ, Whitmore WFJ. Long term results of retropubic permanent 125 iodine implantation of the prostate for clinically localized prostatic cancer. J Urol 1997;158(1):23-9. http://dx.doi.org/10.1097/00005392-199707000-00005
- 5. Holm HH, Gammelgaard J. Ultrasonically guided precise needle placement in the prostate and the seminal vesicles. J Urol 1981;125(3):385-7.
- 6. Yoshioka Y, Konishi K, Oh RJ, et al. High-dose-rate brachytherapy without external beam irradiation for locally advanced prostate cancer. Radiother Oncol 2006;80(1):62-8. http://dx.doi.org/10.1016/j.radonc.2006.06.011
- 7. Demanes DJ, Rodriguez RR, Schour L, et al. High dose rate intensity modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy's 10-year results. Int J Radiat Oncol Biol Phys 2005;61(5):1306-16. http://dx.doi.org/10.1016/j.ijrobp.2004.08.014
- 8. Mark RJ, Akins RS, Anderson PJ, et al. Interstitial high dose rate (HDR) brachtherapy as monotherapy for early stage prostate cancer: a report of 206 cases. Int J Radiat Oncol Biol Phys 2007;69(3 (suppl 1)):329. http://dx.doi.org/10.1016/j.ijrobp.2007.07.1399
- 9. Martinez AA, Demanes J, Vargas C, et al. High dose rate prostate brachytherapy: an excellent accelerated hypofractionated treatment for favorable prostatecancer. Am J Clin Oncol 2010;33(5):481-8. http://dx.doi.org/10.1097/COC.0b013e3181b9cd2f
- 10. Vicini FA, Martinez A, Hanks G, et al. An inter institutional and inter specialty comparison of treatment outcome data for patients with prostate carcinoma based on predefined prognostic categories and minimum follow-up. Cancer 2002;95(10):2126-35. http://dx.doi.org/10.1002/cncr.10919
- 11. Hoskin PJ, Colombo A, Henry A, et al. GEC/ESTRO recommendations on high dose rate afterloading brachytherapy for localised prostate cancer: An update. Radiotherapy and Oncology 2013;107:325-32. http://dx.doi.org/10.1016/j.radonc.2013.05.002
- 12. Kovács G, Cosset JM, Carey B. Focal radiotherapy as focal therapy of prostate cancer. Curr Opin Urol 2014;24(3):231-5. http://dx.doi.org/10.1097/MOU.0000000000000042
- 13. Martinez AA, Pataki I, Edmundson G, et al. Phase II prospective study of theuse of conformal high dose rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: A feasibility report. Int J Radiat Oncol Biol Phys 2001;49(1):61-9. http://dx.doi.org/10.1016/S0360-3016(00)01463-2
- 14. Braeckman J, Autier P, Soviany C, et al. The accuracy of transrectal ultrasonography supplemented with computer-aided ultrasonography for detecting small prostate cancers. BJU Int 2008;102(11):1560-5. http://dx.doi.org/10.1111/j.1464-410X.2008.07878.x
- 15. Simmons LA, Autier P, Zát'ura F, et al. Detection, localisation and characterisation of prostate cancer by prostate HistoScanning((TM)). BJU Int 2012;110(1):28-35. http://dx.doi.org/10.1111/j.1464-410X.2011.10734.x
- 16. Salomon G, Spethmann J, Beckmann A, et al. Accuracy of HistoScanning(TM) for the prediction of a negative surgical margin in patients undergoing radical prostatectomy. BJU Int 2013;111(1):60-6. http://dx.doi.org/10.1111/j.1464-410X.2012.11396.x
- 17. Yoshioka Y, Nose T, Yoshida K, et al. High dose rate interstitial brachytherapy as a monotherapy for localized prostate cancer: treatment description and preliminary results of a phase I/II clinical trial. Int J Radiat Oncol Biol Phys 2000;48(3):675-81. http://dx.doi.org/10.1016/S0360-3016(00)00687-8
- 18. Martin T, Baltas D, Kurek R, et al. 3-D conformal HDR brachytherapy as monotherapy for localized prostate cancer. A pilot study. Strahlenther Onkol 2004;180(4):225-32. http://dx.doi.org/10.1007/s00066-004-1215-4
- 19. Corner C, Rojas AM, Bryant L, et al. A phase II study of high dose rate after loading brachytherapy as monotherapy for the treatment of localized prostate cancer. Int J Radiat Oncol Biol Phys 2008;72(2):441-6. http://dx.doi.org/10.1016/j.ijrobp.2007.12.026
- 20. Wang Y, Sankreacha R, Al-Hebshi A, et al. Comparative study of dosimetry between high dose rate and permanent prostate implant brachytherapies in patients with prostate adenocarcinoma. Brachytherapy 2006;5(4):251-5. http://dx.doi.org/10.1016/j.brachy.2006.08.006
- 21. Demanes DJ, Martinez AA, Ghilezan M, et al. Highdose-rate monotherapy: Safe and effective brachytherapy for patients with localized prostate cancer. Int J Radiat Oncol Biol Phys 2011;81(5):1286-92. http://dx.doi.org/10.1016/j.ijrobp.2010.10.015
- 22. Grills IS, Martinez AA, Hollander M, et al. High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds. J Urol 2004;171(3):1098-104. http://dx.doi.org/10.1097/01.ju.0000113299.34404.22
- 23. Stock RG. High dose rate versus low dose rate monothe rapy in the treatment of localized prostate cancer: The case for low dose rate monotherapy. Brachytherapy 2006;5(1):5-6. http://dx.doi.org/10.1016/j.brachy.2006.01.003
- 24. Sylvester JE. High dose rate versus low dose rate monotherapy in the treatment of localized prostate cancer. The case for high dose rate monotherapy: An up and coming treatment option for low risk prostate cancer. Brachytherapy 2006;5(1):1-4. http://dx.doi.org/10.1016/j.brachy.2006.01.001
- 25. Martinez AA, Demanes DJ, Galalae R, et al. Lack of benefit from a short course of androgen deprivation for unfavorable prostate cancer patients treated with an accelerated hypofractionated regime. Int J Radiat Oncol Biol Phys 2005;62:1322-31. http://dx.doi.org/10.1016/j.ijrobp.2004.12.053
- 26. Galalae RM, Martinez A, Nuernberg N, et al. Hypofractionated conformal HDR brachytherapy in hormone naïve men with localized prostate cancer. Is escalation to very high biologically equivalent dose beneficial in all prognostic risk groups? Strahlenther Onkol 2006;182(3):135-41. http://dx.doi.org/10.1007/s00066-006-1448-5
- 27. Galalae RM, Martinez A, Mate T, et al. Long term outcome by risk factors using conformal high dose rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer. Int J Radiat Oncol Biol Phys 2004;58(4):1048-55. http://dx.doi.org/10.1016/j.ijrobp.2003.08.003
- 28. Pellizzon AC, Nadalin W, Salvajoli JV, et al. Results of high dose rate after loading brachytherapy boost to conventional external beam radiation therapy for initial and locally advanced prostate cancer. Radiother Oncol 2003;66(2):167-72. http://dx.doi.org/10.1016/S0167-8140(02)00408-5
- 29. Aström L, Pedersen D, Mercke C, et al. Long term outcome of high dose rate brachytherapy in radiotherapy of localised prostate cancer. Radiother Oncol 2005;74(2):157-61. http://dx.doi.org/10.1016/j.radonc.2004.10.014
- 30. Hoskin PJ, Rojas AM, Bownes PJ, et al. Randomised trial of external beam radiotherapy alone or combined with high dose rate brachytherapy boost for localised prostate cancer. Radiotherapy and Oncology 2012;103(2):217-22. http://dx.doi.org/10.1016/j.radonc.2012.01.007
- 31. Alexianu M, Weiss GH. Radical prostatectomy versus brachytherapy for early stage prostate cancer. J Endourol 2000;14(4):325-8. http://dx.doi.org/10.1089/end.2000.14.325
| APA | ÖZEN A, PARLAR S, SAYNAK M, ÇALOĞLU H, UZAL M (2016). Prostat Kanseri Tedavisinde Yüksek Doz Hızında Brakiterapi Uygulaması. , 92 - 98. |
| Chicago | ÖZEN Alaattin,PARLAR SULE,SAYNAK Mert,ÇALOĞLU Hasan Murat,UZAL Mustafa Cem Prostat Kanseri Tedavisinde Yüksek Doz Hızında Brakiterapi Uygulaması. (2016): 92 - 98. |
| MLA | ÖZEN Alaattin,PARLAR SULE,SAYNAK Mert,ÇALOĞLU Hasan Murat,UZAL Mustafa Cem Prostat Kanseri Tedavisinde Yüksek Doz Hızında Brakiterapi Uygulaması. , 2016, ss.92 - 98. |
| AMA | ÖZEN A,PARLAR S,SAYNAK M,ÇALOĞLU H,UZAL M Prostat Kanseri Tedavisinde Yüksek Doz Hızında Brakiterapi Uygulaması. . 2016; 92 - 98. |
| Vancouver | ÖZEN A,PARLAR S,SAYNAK M,ÇALOĞLU H,UZAL M Prostat Kanseri Tedavisinde Yüksek Doz Hızında Brakiterapi Uygulaması. . 2016; 92 - 98. |
| IEEE | ÖZEN A,PARLAR S,SAYNAK M,ÇALOĞLU H,UZAL M "Prostat Kanseri Tedavisinde Yüksek Doz Hızında Brakiterapi Uygulaması." , ss.92 - 98, 2016. |
| ISNAD | ÖZEN, Alaattin vd. "Prostat Kanseri Tedavisinde Yüksek Doz Hızında Brakiterapi Uygulaması". (2016), 92-98. |
| APA | ÖZEN A, PARLAR S, SAYNAK M, ÇALOĞLU H, UZAL M (2016). Prostat Kanseri Tedavisinde Yüksek Doz Hızında Brakiterapi Uygulaması. Okmeydanı Tıp Dergisi, 32(2), 92 - 98. |
| Chicago | ÖZEN Alaattin,PARLAR SULE,SAYNAK Mert,ÇALOĞLU Hasan Murat,UZAL Mustafa Cem Prostat Kanseri Tedavisinde Yüksek Doz Hızında Brakiterapi Uygulaması. Okmeydanı Tıp Dergisi 32, no.2 (2016): 92 - 98. |
| MLA | ÖZEN Alaattin,PARLAR SULE,SAYNAK Mert,ÇALOĞLU Hasan Murat,UZAL Mustafa Cem Prostat Kanseri Tedavisinde Yüksek Doz Hızında Brakiterapi Uygulaması. Okmeydanı Tıp Dergisi, vol.32, no.2, 2016, ss.92 - 98. |
| AMA | ÖZEN A,PARLAR S,SAYNAK M,ÇALOĞLU H,UZAL M Prostat Kanseri Tedavisinde Yüksek Doz Hızında Brakiterapi Uygulaması. Okmeydanı Tıp Dergisi. 2016; 32(2): 92 - 98. |
| Vancouver | ÖZEN A,PARLAR S,SAYNAK M,ÇALOĞLU H,UZAL M Prostat Kanseri Tedavisinde Yüksek Doz Hızında Brakiterapi Uygulaması. Okmeydanı Tıp Dergisi. 2016; 32(2): 92 - 98. |
| IEEE | ÖZEN A,PARLAR S,SAYNAK M,ÇALOĞLU H,UZAL M "Prostat Kanseri Tedavisinde Yüksek Doz Hızında Brakiterapi Uygulaması." Okmeydanı Tıp Dergisi, 32, ss.92 - 98, 2016. |
| ISNAD | ÖZEN, Alaattin vd. "Prostat Kanseri Tedavisinde Yüksek Doz Hızında Brakiterapi Uygulaması". Okmeydanı Tıp Dergisi 32/2 (2016), 92-98. |
